We hope you’re sitting comfortably with a freshly brewed Beverage of choice – the best way to read our next instalment of ‘The Daisy Digest.’
With the cancellation of elective surgery over the last two months and much of the media focused on COVID19, we were delighted to see the recent re-launch of ‘Orteq’, one of our supplier partners.
Orteq have been offering joint preservation solutions for orthopaedic and sports medicine surgeons since 2005 providing products which encourage the patient’s own natural healing process.
In recent weeks Orteq have launched a new website, creating a central hub for patients and clinicians wishing to find out more in terms of product processes, clinical data and surgical techniques for both Actifit® and CartiONE™
On the 1st of April 2020 Orteq’s Meniscal Scaffold product, ‘ACTIfit,’ was given FDA Breakthrough Designation. This is a well-deserved accreditation for a product which has consistentley delivered great results with us.
Last week The American Journal of Sports Medicine also published the ACTIfit 5 year follow up results. Press the button below to read the paper in full.